COVID-19: A Message from Our CEO
"As the COVID-19 pandemic evolves, CSL remains committed to safeguarding our patients, our donors and our people. In keeping with our values-based culture, CSL has taken precautions to ensure our employees and our facilities remain safe so we can continue to deliver on our promise to patients and public health." - Paul Perreault, CEO & Managing Director, CSL LimitedRead Our Letter to Patients
Learn, Interact and Celebrate
Rare Disease Day 2021 is happening amid a global pandemic. Here are three safe ways to take part.
Standing Up for Rare Disease Patients in Europe
“Donating plasma saves lives,” says CSL Behring’s General Manager for Commercial Operations in Europe.
"Why I Donate Plasma"
CSL employees share how helping patients is simply a matter of rolling up their sleeves.
CSL CEO Paul Perreault on Rare Disease Day
See the video Perreault shared with employees: “Reflect on the work we do and the people who count on us to keep innovating.”
What I Learned During the Pandemic
A site leader in Australia says the experience revealed strengths and reinforced relationships among team members.
The Heart of the Matter
In honor of Heart Month, our cardiovascular experts share why they’re committed to fighting heart disease and improving publi…
Diabetes & Kidney Disease
Global rise in cases of diabetes and related kidney disease prompts search for new treatments.
What to Tell the Kids About COVID-19?
A walk to kindergarten with a group of 5-year-olds gave a CSL Behring scientist an idea for a timely children’s book.